Neurological examination at 6 to 9 months in infants with cystic periventricular leukomalacia

D Ricci1, F Cowan, M Pane

  • 1Paediatric Neurology Unit, Catholic University, Rome, Italy. daniricciola@libero.it

Neuropediatrics
|December 21, 2006
PubMed

Insights

Neurological examination in infants with cystic periventricular leukomalacia (PVL) between 6-9 months can predict motor outcomes. Specific tone patterns and optimality scores help forecast motor sequelae at two years.

Area of Science:

  • Neonatal Neurology
  • Pediatric Neurology
  • Developmental Pediatrics

Background:

  • Cystic periventricular leukomalacia (PVL) is a common form of brain injury in preterm infants.
  • PVL can lead to significant motor impairments, including cerebral palsy.
  • Early identification of neurodevelopmental risks is crucial for timely intervention.

Purpose of the Study:

  • To identify neurological abnormality patterns in infants with PVL.
  • To determine optimality scores predicting motor sequelae severity.
  • To correlate early neurological findings with motor function at two years of age.

Main Methods:

  • Hammersmith Infant Neurological Examination administered to 24 infants with PVL (gestational age 26-38 weeks).
  • Examinations conducted between 6 and 9.5 months corrected age.
  • Motor function (sitting, walking) assessed at 2 years corrected age.

Main Results:

  • Increased neck/trunk extensor tone with flexed arms/extended legs predicted inability to sit unsupported at 2 years.
  • Truncal hypotonia with extended arms/legs correlated with sitting ability but not walking.
  • Optimality scores: 41-60 predicted sitting but not walking; <40 predicted inability to sit independently.
  • Scores >60 were associated with the absence of cerebral palsy at 2 years.

Conclusions:

  • Neurological examination findings between 6-9 months are predictive of motor impairment in infants with PVL.
  • Optimality scores derived from these examinations offer valuable prognostic information.
  • Early assessment aids in predicting the severity of motor sequelae in infants with PVL.